Long-acting bronchodilators in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 6, 2003, Pages 504-508

  Colombo, John L ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Beta adrenergic agonists; Bronchodilators in CF; Mucociliary clearance

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BACTERIUM ADHERENCE; BRONCHUS HYPERREACTIVITY; CELL FUNCTION; CYSTIC FIBROSIS; DRUG EFFECT; DRUG MEGADOSE; DRUG UTILIZATION; ECG ABNORMALITY; HUMAN; HYPERTENSION; INFECTION CONTROL; INFLAMMATION; INFLAMMATORY CELL; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PRESCRIPTION; PROTEIN FUNCTION; RESPIRATORY SYSTEM; REVIEW; SMOOTH MUSCLE RELAXATION; STATISTICAL SIGNIFICANCE; TACHYCARDIA;

EID: 0142074349     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200311000-00010     Document Type: Review

References (20)

1. Johnson C, Butler S, Konstan M, et al.: Factors influencing outcomes in cystic fibrosis. Chest 2003, 123:20-27.
2. Zach M, Oberwalder B, Forche F et al.: Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis 1985, 131:537-543.
3. Balfour-Lynn IM and Elborn JS: "CF asthma": what is it and what do we do about it? Thorax 2002, 57:742-748.
4. Nickerson B, Lemen R, Gerdes C, et al.: Within-subject variability and percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 1980, 122:859-866.
5. Cropp J: Effectiveness of bronchodilators in cystic fibrosis. Am J Med 1996, 29;100:19S-29S.
6. Van Haren E, Lammers J, Festen J, et al.: Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways. Eur Respir J 1991, 4:301-307.
7. Sanchez I, Coaster DE, Koster J, Holbrow J, et al.: The effects of high doses of salbutamol and ipratropium bromide in patients with stable cystic fibrosis. Chest 1993, 104:842-846.
8. Weinberger M: Airways reactivity in patients with CF. Clin Rev Allergy Immunol 2002, 23:77-85.
9. Jaffe A and Balfour-Lynn I: Treatment of severe small airways disease in children with cystic fibrosis. Alternatives to corticosteroids. Pediatr Drugs 2002, 4:381-389.
10. Hordvik N, Sammut P, Judy C, et al.: The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis. Am J Resp Crit Care Med 1996, 154:156-160.
11. König P, Poehler J, Barberro G: A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis. Pediatr Pulmonol 1998, 25:32-37.
12. Sestini P, Renzoni E, Robinson S, et al.: Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease. Cochrane Library 2003, 2.
13. Appleton S, Poole P, Smith B, et al.: Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation. Cochrane Library 2003, 2.
14. Salvatore D and D'Andria M: Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis. Pediatr Pulmonol 2002, 34:11-15.
15. Hordvik N, Sammut PH, Gerald JC, et al.: Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis. Pediatr Pulmonol 2002, 34:287-296. A six-month double-blind, controlled study showing improvement in spirometry and other clinical outcomes treating CF patients with salmeterol.
16. 2-adrenergic receptor increases cystic fibrosis transmembrane conductance regulator expression in human airway epithelial cells through a cAMP/protein kinase A-independent pathway. J Biol Chem 2003, 278:17320-17327. Demonstrated in vitro increase in CFTR protein expression with salmeterol applied to human airway epithelial cells. Immunohistochemistry demonstrated localization of CFTR and beta2-adrenergic receptor to the apical membrane of the epithelial cells.
17. Bennet WD: Effect of Beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002, 110:S291-S297. Concise, yet thorough review, discussing measurement of mucociliary clearance and mechanisms of alteration by beta-adrenergic drugs.
18. Sheppard D, Welsh M: Structure and function of the CFTR chloride channel. Physiol Rev 1999, 79:S23-S45.
19. Yang Y, Devor D, Engelhardt K, et al.: Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet 1993, 2:1253-1261.
20. Buscher R, Eilmes K, Graseman H, et al.: Beta2-adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 2002, 12: 347-353.